DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers

Information source: University Hospital, Grenoble
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy

Intervention: treprostinil (Drug); iloprost (Drug); NaCl 0.9% (Drug)

Phase: Phase 1/Phase 2

Status: Completed

Sponsored by: University Hospital, Grenoble

Summary

The purpose of this study is to test whether prostacyclin analogues' cathodal iontophoresis induce a cutaneous vasodilation in healthy volunteers's forearm, without local side effects.

Clinical Details

Official title: Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Amplitude of forearm cutaneous vasodilatation assessed using laser Doppler imaging

Secondary outcome: Local tolerance assessed clinically

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- healthy volunteers

- age above 18

Exclusion Criteria:

- any chronic disease

- any drug intake

Locations and Contacts

Unité de Pharmacologie Clinique, Inserm CIC3, CHU Grenoble, Grenoble 38043, France
Additional Information

Starting date: January 2010
Last updated: October 5, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017